8-K: Intuitive Surgical Reports Strong Q4 2024 Results, Announces Acquisition to Expand European Presence

Intuitive Surgical's Q4 2024 revenue increased by 25% year-over-year, driven by procedure growth and system placements, while the company also announced plans to acquire its distribution businesses in select European countries.

Summary

• Intuitive Surgical announced its Q4 2024 financial results, reporting a 25% increase in revenue to $2.41 billion compared to $1.93 billion in Q4 2023.
• Worldwide da Vinci procedures grew by approximately 18% compared to the same period last year.
• The company placed 493 da Vinci surgical systems in Q4 2024, including 174 da Vinci 5 systems, compared to 415 systems in Q4 2023.
• Intuitive's installed base of da Vinci systems reached 9,902 as of December 31, 2024, a 15% increase year-over-year.
• GAAP net income attributable to Intuitive was $686 million, or $1.88 per diluted share, compared to $606 million, or $1.69 per diluted share, in Q4 2023.
• Non-GAAP net income attributable to Intuitive was $805 million, or $2.21 per diluted share, compared to $574 million, or $1.60 per diluted share, in Q4 2023.
• The company expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025.
• Intuitive also announced it will acquire its da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, and San Marino for approximately $290 million upfront and up to $31 million in milestone payments, with the deal expected to close in the first half of 2026.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, procedure growth, and strategic expansion plans. While there are some concerns about potential margin compression and increased operating expenses, the overall tone is optimistic.

Positives

• Strong revenue growth of 25% in Q4 2024 indicates increasing demand for Intuitive's products and services.
• The 18% growth in da Vinci procedures demonstrates continued adoption of robotic-assisted surgery.
• Increased system placements, including the da Vinci 5, suggest strong customer interest in Intuitive's latest technology.
• The growing installed base provides a recurring revenue stream through instruments, accessories, and services.
• The acquisition of distribution businesses in Europe will allow Intuitive to have a more direct relationship with customers and better understand their needs.

Negatives

• The expected non-GAAP gross profit margin for 2025 is projected to be within a range of 67% and 68% of net revenue, compared to 69.1% in 2024, indicating a potential decrease in profitability.
• Non-GAAP operating expense growth is expected to be within a range of 10% to 15% in 2025, compared to 10% in 2024, suggesting increased spending.
• The company notes that the 2025 gross profit margin range does not include any potential impact of new tariffs on their business, which could be material.

Risks

• The overall macroeconomic environment, including tariffs, inflation, and interest rates, could impact customer spending and the company's costs.
• Conflicts in Ukraine and the Middle East could disrupt the company's supply chain.
• Delays in obtaining new product approvals from regulatory bodies could impact the company's growth.
• Healthcare reform legislation in the U.S. could impact hospital spending and reimbursement.
• Unanticipated manufacturing disruptions or the inability to meet demand for products could negatively affect the company's performance.

Future Outlook

The company expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025. Non-GAAP gross profit margin is expected to be within a range of 67% and 68% of net revenue in 2025. Non-GAAP operating expense growth is expected to be within a range of 10% to 15% in 2025.

Management Comments

• Intuitive CEO Gary Guthart stated that having a direct presence in Italy, Spain, Portugal, Malta, and San Marino allows the company to deepen its understanding of unique customer needs in these countries.
• Senior Vice President and General Manager Dirk Barten expressed gratitude for the strong business and dedication provided by the distributors and looked forward to integrating these teams upon deal closure.
• ab medica CEO Francesca Cerruti stated that they are proud to have introduced robotic-assisted surgery more than two decades ago in Italy and Southern Europe and will continue on their path of innovation in service of patients, care, and healthcare professionals.

Industry Context

The announcement reflects a broader trend of medical device companies seeking to establish more direct relationships with customers in key markets. This allows for better control over distribution, service, and market insights, potentially leading to increased market share and customer satisfaction. Other companies in the robotic surgery space, such as Medtronic and Stryker, are also investing in expanding their global presence and direct sales capabilities.

Comparison to Industry Standards

• Intuitive Surgical's procedure growth of 18% in Q4 2024 is strong compared to the overall growth rate of the surgical robotics market.
• Companies like Stryker and Zimmer Biomet, which also operate in the broader surgical space, have reported varying growth rates depending on their specific product lines and market segments.
• Intuitive's gross profit margin of 69.1% in 2024 is high compared to many other medical device companies, reflecting its strong market position and premium pricing.
• Medtronic, for example, typically has gross profit margins in the 60-70% range.
• The planned acquisition of distribution businesses is similar to strategies employed by other medical device companies to gain more control over their sales and service channels in key international markets.

Stakeholder Impact

• Shareholders will likely react positively to the strong financial results and strategic acquisition.
• Employees of the acquired distribution businesses will be integrated into Intuitive's European commercial and marketing organization.
• Customers in Italy, Spain, Portugal, Malta, and San Marino will benefit from a more direct relationship with Intuitive.
• Patients will potentially have greater access to minimally invasive care through the expansion of da Vinci and Ion systems.

Next Steps

• Intuitive will hold a teleconference to discuss the fourth quarter 2024 financial results.
• The company expects to complete the acquisition of distribution businesses in Europe in the first half of 2026, subject to customary closing conditions.
• Intuitive will continue to focus on driving procedure growth, expanding its installed base, and developing new technologies.

Key Dates